Sorry, you need to enable JavaScript to visit this website.

This site is intended only for healthcare professionals resident in the United Kingdom

Prescribing information can be found at the bottom of the page

For the short-term treatment of postoperative pain in adults age 18 and over.'

A compelling choice for the short-term management of postoperative pain

  1. Fast, long-lasting relief of moderate-to-severe postoperative pain
    1. Rapid onset from 7-13 minutes:1 peak effect within 2 hours (IM or IV)1
    2.  Long duration: up to 11 hours in hernia repair2 and from >5 to 8.7 hours in a variety of surgical procedures after a single dose3,4
  2. Can be used with opioids as part of a multimodal approach1
    1. Significant reductions in cumulative opioid use vs placebo in a variety of surgical procedures (p<0.05)5-7
  3.  An established tolerability profile
    1. Little to no effect on bleeding time or platelet aggregation8
    2. Incidence of gastrointestinal ulcers/erosions significantly lower than with NSAIDs1,9
    3. In one study, 5-21% gastroduodenal ulcers or erosions with parecoxib vs 66-90% with NSAIDs, and 10% duodenal ulcer/erosion with parecoxib vs 45% with an NSAID (p<0.05 for both)9
  4. Convenient twice daily IV or IM dosing1
    1. Can be administered preoperatively, intraoperatively and postoperatively
Learn about dosing

An injectable COX-2 selective NSAID indicated for the short-term management of postoperative pain in adults1

Resources & Training

Find related information and test your knowledge with bespoke training modules

Find out more

Stock Hub

Register here to receive real time stock information and email alerts 

Access the Stock Hub

COX: cyclooxygenase; IV: intravenous; IM: intramuscular; NSAID: nonsteroidal anti inflammatory drug

References

  1. Pfizer Ltd. Dynastat 40 mg Powder for Solution for Injection. Summary of Product Characteristics. 
  2. Kyriakidis AV, et al. Hernia. 2011;15:59–64. 
  3. Barden J, et al. BMC Anesthesiology. 2003;3:1.
  4. Malan TP Jr, et al. Anesth Analg. 2005, 100:454–460.
  5. Malan TP Jr, et al. Anesthesiology, 2003; 98:950-956.
  6. Hubbard RC, et al. Br J Anaesth. 2003;90(2):166–72.
  7. Essex MN, et al. Int J Gen Med. 2017; 10:319-327.
  8. Noveck RJ, et al. Clin Drug Invest. 2001;21:465–76. 
  9. Stoltz RR, et al. Am J Gastroenterol. 2002;97:65–71.